Cogentin® (benztropine mesylate)

This section provides a summary of the drug information for Cogentin® (benztropine mesylate).

If you have any further questions about your PD medication, or other aspects of your PD treatment, you should discuss these with your doctor or other healthcare professional.

Cogentin® is an anticholinergic medication used for the treatment of drug-induced parkinsonism, akathisia and acute dystonia, Parkinson disease and idiopathic or secondary dystonia. Benztropine is used in the treatment of Parkinson's disease to reduce the side effects of certain antipsychotic medicines.

Benztropine injection works by reducing the stiffness and abnormal movements. In tablet form it was also used to treat Parkinson's disease but tablets are no longer available in the UK - Cogentin® is available on named patient basis through treatment centres from specialist importing companies.

Cogentin® is also known by the following international brand names:

  • Bentrop (AU)
  • Cogentin (AU, GB, HK, IE, MY, PT, SE)

Product information downloads

The information on this pageprintout is a general summary of the Cogentin® medication product.

Please click on the links below to download more detailed information on the specific Cogentin® medication, its handling and use. Links go to the Ovation Pharmaceuticals and Merck & Co., Inc. websites.

Further detailed information on the Cogentin® medication, its handling and use can be downloaded via the Ovation Pharmaceuticals and Merck & Co., Inc. websites:

Patient Information Leaflets (PIL)

Summary of Product Characteristics (SPC)

Please note that SPCs are designed for healthcare professionals.

 

Cogentin® (benztropine mesylate) is a registereed trademark of Merck & Co., Inc.